News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Hepatitis B
Launch of New Patient-Focused Website at LiverCancerConnect.org

The website aims to help people better understand how liver cancer is diagnosed and how it can be treated or prevented. In addition, wwwLiverCancerConnect.org includes a Drug Watch of potential new liver cancer therapies, an expanding directory of liver cancer specialists, and a clinical trials listing.

Published
07 February 2013
From
Hepatitis B Foundation
Hepatitis B
NICE issues draft guideline for consultation on the diagnosis and management of hepatitis B

NICE is currently developing a new clinical guideline on the diagnosis and management of chronic hepatitis B in children, young people and adults. Draft recommendations have been published on the NICE website today (17 January) for public consultation.

Published
17 January 2013
From
NICE press release
Hepatitis B
Hepatitis B treatment and care in the UK need to evolve to keep pace with the global epidemic

“Persistent HBV [hepatitis B virus] infection has changed its face in the UK,” research published in the online edition of Clinical Infectious Diseases shows. The study found considerable

Published
09 January 2013
By
Michael Carter
Cancer
Liver cancer has a more aggressive disease course in HIV-positive people co-infected with viral hepatitis

Co-infection with HIV and viral hepatitis is associated with a more aggressive disease course for liver cancer, according to research conducted in London and presented to the

Published
18 December 2012
By
Michael Carter
Hepatitis B
Adding pegylated interferon to entecavir improves hepatitis B treatment response

Intensifying entecavir (Baraclude) treatment for hepatitis B by adding pegylated interferon lowers HBV viral load and increases the likelihood of hepatitis B "e" antigen (HBeAg) loss, according

Published
13 December 2012
By
Liz Highleyman
Hepatitis C
New NICE public health guidance aims to ensure more people at increased risk of hepatitis B and C infection are tested

New guidance published today (12 December) by healthcare guidance body NICE highlights the need to tackle ignorance about the risk factors and causes of hepatitis B and C, and misconceptions about its treatment if barriers to effective testing of those at increased risk of infection are to be overcome.

Published
12 December 2012
From
NICE
Cancer
Brivanib fails to match sorafenib for liver cancer, but tivantinib looks promising

The investigational cancer drug brivanib did not significantly increase survival for people with hepatocellular carcinoma over existing standard therapy, researchers reported at the recent Liver Meeting 2012,

Published
05 December 2012
By
Liz Highleyman
Hepatitis B
Nucleoside analogues reduce hepatitis B liver cancer risk

Treatment of chronic hepatitis B with nucleoside analogues including lamivudine (Epivir) and entecavir (Baraclude) can reduce the risk of developing hepatocellular carcinoma, including cancer recurrence after successful resection

Published
29 November 2012
By
Liz Highleyman
HIV treatment in children
European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

New oral granule formulation and lower-strength tablets available for new indications.

Published
28 November 2012
From
Gilead press release
Hepatitis B
Tenofovir safe and effective for long-term hepatitis B treatment with little bone loss

Tenofovir (Viread) continues to be safe and effective for treating chronic hepatitis B through eight years of follow-up, researchers reported at The Liver Meeting 2012, the 63rd

Published
22 November 2012
By
Liz Highleyman
← Prev12345...7Next →

Filter by country